In Other News

• New Blood Test Predicts Organ-Specific Disease and Mortality Years in Advance

• Genomic Assay Predicts Recurrence Risk in Noninvasive Breast Cancer

• Stain-Free Imaging Platform Matches Standard Cancer Pathology

• New Findings Clarify Molecular Drivers of Rare Small Intestinal Cancer

• Partnership Expands Ultrasensitive Blood-Based Diagnostics for Hematologic Malignancies

• New Blood Test Predicts Organ-Specific Disease and Mortality Years in Advance

• Long-Read DNA Test Improves Diagnosis of Rare Genetic Diseases

• New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

• Antibody Profiles Provide Clues to Long COVID Severity and Symptoms

• At-Home Urine Collection Kit Enables High-Throughput STI Screening

• Noninvasive Sequencing Test Approaches Invasive Genome Sequencing for Prenatal Screening

• Blood-Based Assay Detects HER2 Mutations to Guide NSCLC Treatment

• Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

• Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia

• New Protein Targets Support Diagnostics for Louse-Borne Relapsing Fever

• Antibody Profiling Supports Evaluation of Long COVID and Cognitive Symptoms

• New Protein Targets Support Diagnostics for Louse-Borne Relapsing Fever

• Ultrasensitive HPV Blood Test Predicts Early Recurrence in Head and Neck Cancer

• Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

• Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

• Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging

• Open-Source Consortium Aims to Standardize Digital Pathology Workflows

• AI Tool Speeds Brain Tumor Classification from Routine Histology Slides